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Summary
Background Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health 
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and 
the Organisation for Economic Co-operation and Development (OECD) policy marker. We aimed to compare the 
estimates, trends, and methodologies of these initiatives and make recommendations for future aid tracking.
Methods We compared estimates of aid for RMNCH from the four initiatives for all years available at the time of our 
analysis (1990–2016). We used publicly available datasets for IHME and Countdown. We produced estimates for 
Muskoka and the OECD policy marker using data in the OECD Creditor Reporting System. We sought to explain 
differences in estimates by critically comparing the methods used by each approach to identify and analyse aid, and 
quantifying the effects of these choices on estimates.
Findings All four approaches indicated substantial increases over time in global aid for RMNCH, but estimates of aid 
amounts and year-on-year trends differed substantially, especially for individual donors and recipient countries. 
Muskoka (US$ 13·0 billion in 2013, constant 2015 US$) and Countdown’s RMNCH estimates ($13·1 billion in 2013) 
tended to be the highest and most similar, although they often indicated different year-on-year trends. IHME produced 
lower estimates ($10·8 billion in 2013), which often indicated different trends from the other approaches. The OECD 
policy marker produced by far the lowest estimates ($2·0 billion in 2013) because half of bilateral donors did not 
report on it consistently and those who did tended to apply it narrowly. Estimates differed across approaches primarily 
because of differences in methods for distinguishing aid for RMNCH from aid for other purposes; adjustments for 
inflation, exchange rates, and under-reporting; whether donors were credited for their support to multilateral 
institutions; and the handling of aid to unspecified recipients.
Interpretation The four approaches are likely to lead to different conclusions about whether individual donors and 
recipient countries have fulfilled their obligations and commitments and whether aid was sufficient, targeted to 
countries with greater need, or effective. We recommend that efforts to track aid for the Sustainable Development 
Goals reflect their multisectoral and interconnected nature and make analytical choices that are appropriate to their 
objectives, recognising the trade-offs between simplicity, timeliness, precision, accuracy, efficiency, flexibility, 
replicability, and the incentives that different metrics create for donors.
Funding Subgrant OPP1058954 from the US Fund for UNICEF under their Countdown to 2015 for Maternal, Newborn 
and Child Survival Grant from the Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Estimating how much aid donors give to low-income 
and middle-income countries is essential, but complex. 
Aid estimates are required to hold donors and recipients 
accountable and to assess whether aid is sufficient, 
targeted to need, and effective. The Organisation for 
Economic Co-operation and Develop ment (OECD) 
provides a standardised framework for donor aid 
reporting—the Creditor Reporting System—which 
facilitates estimates of total annual aid flows from 
most donors. However, to evaluate aid flows for 
specific health priorities, total aid flows need to be 
disaggregated.1 This disaggregation can be challenging 
because the categories required for evaluation do not 
always align with the ways in which funds are disbursed 
or reported.
Many resource tracking exercises have estimated the 
value of aid for specific diseases, including malaria,2,3 
tuberculosis,4,5 pneumonia and diarrhoea,6 and HIV;7,8 for 
neglected tropical diseases9,10 and other groups of 
diseases;11–13 for mental health,14,15 newborn health,16,17 and 
reproductive health.18–21 Some resource tracking exercises 
have assessed the distribution of aid across health 
areas.13,22–24 Four initiatives have estimated the value of aid 
for reproductive, maternal, newborn, and child health 
(RMNCH): the Countdown to 2015;25–30 the G8’s Muskoka 
methodology,31 implemented by the Partnership for 
Maternal, Newborn & Child Health (PMNCH);1 the 
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Institute for Health Metrics and Evaluation (IHME);23,32 
and the RMNCH policy marker within the OECD’s 
Creditor Reporting System database (panel).40 Previous 
studies have included comparisons of the first three 
of these RMNCH initiatives and highlighted some of 
the differences in estimates and underlying metho-
dologies.1,25,30 However, to our knowledge, no study to 
date has systematically compared estimated trends and 
amounts of aid for RMNCH across these four approaches 
or examined their methodologies in detail. This under-
investigation represents an important research gap 
because different estimates of aid for RMNCH could 
lead to substantially different conclusions about past 
aid efforts, which could in turn affect future aid 
policies and health outcomes. Policy makers, advocates, 
and academics therefore require informed guidance 
regarding the relative merits of the different approaches, 
how to interpret their estimates, and how best to track 
aid for new global health goals.
In our study, we aimed to compare the estimates and 
trends generated by the four RMNCH aid tracking 
initiatives—including Countdown, with which we were 
involved—and examine how their underlying method-
ologies affected estimates and trends. We aimed to 
inform future efforts to monitor resource flows, notably 
for the Global Strategy for Women’s, Children’s, and 
Adolescents’ Health (2016–2030) and the Sustainable 
Development Goals (SDGs).
Research in context
Evidence before this study
Four initiatives produced estimates of the value of aid for 
reproductive, maternal, newborn, and child health (RMNCH) 
over time, but to our knowledge no studies have systematically 
compared their estimates or methodologies in detail. Policy 
makers and academics thus lack informed guidance regarding 
the relative merits of the different approaches, how to interpret 
their estimates, and how best to track aid for the Sustainable 
Development Goals (SDGs) and the Global Strategy for 
Women’s, Children’s, and Adolescents’ Health.
Added value of this study
Our in-depth comparison showed that the four RMNCH 
tracking initiatives produced substantially different estimates 
of levels and trends in aid for RMNCH, especially for individual 
donors and recipient countries. We explored how 
methodological differences led to these differing estimates and 
trends and found that differences both in the underlying 
conceptual frameworks and in many technical choices 
substantially influenced estimates. At the conceptual level, we 
showed that the approaches measured fundamentally different 
constructs. Muskoka, Countdown, and the Organisation for 
Economic Cooperation and Development (OECD) RMNCH 
policy marker sought to estimate the value of aid supporting 
RMNCH, whereas the Institute for Health Metrics and 
Evaluation (IHME) sought to characterise health sector aid by 
focus area. IHME estimates of aid for RMNCH thus reflect the 
value of aid explicitly described as promoting RMNCH, 
excluding aid oriented towards diseases or the humanitarian 
sector and most health systems funding, even where such aid 
would directly promote RMNCH.
We critically compared the technical choices of each approach 
and the degree to which different choices influenced estimates. 
As half of major donors have not implemented the OECD 
RMNCH policy marker, its estimates are low and uninformative. 
Although Countdown provided the most in-depth approach for 
identifying aid for RMNCH, it was slow and labour-intensive, 
making it not practically replicable, and not readily adaptable to 
new goals. The Muskoka approach was transparent, quick to 
implement, fully replicable, and readily adaptable to new goals, 
but carried a greater risk of misclassifying funding because it 
used high-level assumptions without project-level review. 
IHME’s wider range of data sources led to substantial 
complexity in data management techniques, which were not 
fully replicable, but its techniques for apportioning aid to 
RMNCH were quick to implement, adaptable to new goals, 
largely replicable, and precise. By making substantial 
adjustments to donors’ reported data, IHME generated 
estimates over a much longer time period than the other 
approaches. All four approaches involved many assumptions 
and none included funding for activities in education, 
transport, or social protection; quantified the uncertainty in 
their estimates; or included bilateral aid from China, Russia, 
India, or Brazil.
Implications of all the available evidence
The four approaches are likely to lead to different conclusions 
about whether individual donors and recipient countries have 
fulfilled their obligations and commitments and whether aid 
was sufficient, targeted to countries with greater need, or 
effective. To monitor the flow of funds supporting each SDG 
and the Global Strategy, methods for tracking aid should be 
built on a sound conceptual framework that recognises that 
funding can simultaneously support multiple objectives, even 
if these objectives are not named explicitly in reports of that 
funding. We recommend that future aid tracking efforts begin 
by identifying an explicit conceptual framework and then 
make technical choices appropriate to their objectives, 
recognising the trade-offs between simplicity, timeliness, 
precision, accuracy, efficiency, flexibility, and replicability. For 
accountability exercises, experts and stakeholders should 
consider refining the Muskoka approach to improve its 
precision and accuracy, while maintaining its simplicity and 
replicability. For in-depth analyses addressing specific research 
questions, combining key term searches and use of the OECD 
purpose codes with manual review of a restricted set of 
records could provide a more suitable balance between rigour 
and efficiency.
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Panel: Origins of the Creditor Reporting System purpose codes and four approaches for tracking aid for RMNCH
The OECD’s purpose codes have been used since the Creditor 
Reporting System aid activity database was established in 
1973. The Creditor Reporting System provides a mechanism 
for comparable, detailed aid tracking as a complement to the 
aggregate statistics and sector codes in the OECD 
Development Assistance Committee database, which have 
been used since 1960. The Creditor Reporting System requires 
donors to categorise their funding records by the economic or 
social sector of activity, and within each sector, into a single 
purpose code. Although some sector and purpose codes have 
been added or modified over the years, the overall structure 
has remained unchanged. The number of donors reporting to 
the Creditor Reporting System has increased greatly from the 
15 rich-country bilateral members of the OECD’s Development 
Assistance Committee and five development banks reporting 
in 1973 to 50 bilateral, 35 multilateral, and one private donor 
reporting in 2017. The quality and completeness of data have 
also improved substantially; from 2003 onwards, the Creditor 
Reporting System contains detailed disbursement data for 
more than 90% of the aggregate data reported in the OECD 
Development Assistance Committee database.33 Data are 
initially reported in the Creditor Reporting System with a 
12-month delay following the close of the calendar year of the 
disbursement and revised estimates are reported quarterly 
thereafter.
The Countdown to 2015 was established in 2005 as a 
multidisciplinary, multi-institutional collaboration to 
monitor and promote progress in the countries with the 
worst RMNCH outcomes for health outcomes, coverage of 
key interventions, and determinants of coverage, including 
financing. As the Creditor Reporting System purpose and 
sector codes were not structured to provide data on the value 
of aid supporting specific objectives, the London School of 
Hygiene & Tropical Medicine developed methods initially to 
track the value of funding promoting child health (MDG4), 
and subsequently expanded to include maternal and 
reproductive health. Estimates in total, by donor, and by 
recipient country (in aggregate and per relevant population) 
were published within the Countdown reports in 2008, 2011, 
2013, 2015, and 2016 and as research articles on aid for 
MNCH in 2006,29 2008,26 2010,28 and 2012,27 on reproductive 
health in 2013,18 and on RMNCH in 201525 and 2016.30 
Analyses assessed funding from 2003, the earliest year for 
which relatively complete disbursement data were available, 
to 2013. This initiative continues as the Countdown to 2030, 
with an expanded remit, including adolescents and an explicit 
emphasis on nutrition. Methods for tracking donor financing 
in this next phase are under review.
The IHME was established at the University of Washington in 
2007 with the aim to provide “an impartial, evidence-based 
picture of global health trends to inform the work of 
policymakers, researchers, and funders.”34 In 2009, IHME 
published the first in a series of annual Financing Global 
Health reports.35 Although focused on characterising overall 
aid flows for the health sector since 1990, this report also 
included estimates of the value of aid specifically for HIV, 
malaria, tuberculosis (MDG6), and health sector support to 
examine “whether the distribution of global health resources 
across different disease areas and geographical areas reflect 
current global health priorities… [and] the relationship of 
DAH [development assistance for health] to disease burden.”35 
From 2010, additional health areas, notably MNCH, were 
examined in a series of research articles and in each annual 
report, the latest of which estimated aid through 2017.24,36 We 
analysed the findings32 and methods37 used in IHME’s 2016 
report, which was available at the time of our analysis.
The Muskoka methodology was launched at the G8 summit 
in Muskoka, Canada in 2010, as a mutually agreed approach 
for G8 countries to monitor their own financial support for 
MDGs 4 and 5. The G8’s health working group sought an 
approach that would be fully transparent, straightforward to 
implement, and accepted by donors; account for G8 
members’ core contributions to multilaterals and global 
health initiatives; and appropriately reflect the range of 
sectors that promote RMNCH. To this end, they consulted 
with the OECD, the London School of Hygiene & Tropical 
Medicine, and others, and developed methods, which they 
published online.31 The PMNCH then used the Muskoka 
methods (with a few modifications) to track disbursements in 
fulfilment of commitments to the Global Strategy for 
Women’s and Children’s Health (2010–15) in their annual 
accountability reports. The G8 set 2007 as the baseline 
against which to measure their subsequent disbursements, 
PMNCH reported on 2006–14, and we generated estimates 
using PMNCH’s latest methods for estimating RMNCH 
disbursements for 2002–15.
The OECD’s RMNCH policy marker was introduced on a trial 
basis in 2014 for reporting on flows from 2013 onwards 
within the Creditor Reporting System, following 
recommendations of the Commission on Information and 
Accountability for Women’s and Children’s Health and the 
Muskoka Initiative.38 Each policy marker in the Creditor 
Reporting System is a single, additional variable that 
indicates the degree to which the donor believes its 
disbursement supports a given cross-sectoral policy area 
(eg, the environment).39 Donors are expected to code each 
policy marker in addition to the purpose code for each 
disbursement record. In 2016, the OECD decided to fully 
adopt the RMNCH policy marker, although its specific coding 
framework remains under review.
RMNCH=reproductive, maternal, newborn, and child health. OECD=Organisation for 
Economic Co-operation and Development. MDG=Millenium Development Goal. 
MNCH=maternal, newborn, and child health. IHME=Institute for Health Metrics and 
Evaluation. PMNCH=Partnership for Maternal, Newborn, and Child Health.
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Methods
Comparison of estimates
To compare RMNCH aid disbursement levels and trends, 
we used the most recent publicly available datasets for 
IHME41 and Countdown42 at the time of our analysis and 
used the June, 2017, version of the Creditor Reporting 
System to produce estimates for the Muskoka method31 
and the OECD policy marker.40 Previously published 
estimates1 for the Muskoka method did not present 
data for all recipient countries or annual data by donor 
and recipient country. To our knowledge, OECD policy 
marker estimates have not previously been published. 
We are not aware of other methods to generate estimates 
of aid for RMNCH as a whole.
We presented five metrics: Countdown’s estimates of 
RMNCH and MNCH, Muskoka’s RMNCH estimate, the 
RMNCH policy marker, and IHME’s MNCH estimate 
(panel). We refer to these as estimates of aid for RMNCH, 
although each approach defined its metric(s) in different 
ways. In particular, Countdown created separate RMNCH 
and MNCH categories, while IHME defined its MNCH 
category to include both reproductive health and family 
planning. The initiatives reported on aid for RMNCH 
over different but overlapping time periods (panel), so we 
present all reported years but only compared aid levels 
and trends for years reported on by more than one 
initiative.
We used line graphs to compare estimates and trends 
in aid for RMNCH for all countries and for the 
75 Countdown to 2015 priority recipients (based on 
health need; appendix). We also compared estimates by 
individual donor for 24 donors (longstanding members 
of the OECD’s Development Assistance Committee, 
including the European Union [EU]) and by individual 
recipient for 24 recipients (the nine countries with the 
worst levels in 2013 for each of five indicators:43 maternal 
mortality ratio, number of maternal deaths, mortality 
in children younger than 5 years, number of deaths in 
children under 5 years, and female life expectancy). We 
explored whether the choice of aid tracking approach 
would affect conclusions about the association between 
aid and mortality using scatter plots of aid for RMNCH 
per child under 5 years44 compared with the under-5 
mortality rate for each of the 75 priority countries using 
data for 2013. Estimates are presented in constant 2015 
US$.
Comparison of methods
We did an in-depth comparison of the methods 
underpinning each aid tracking initiative to explain 
similarities and differences in resulting aid estimates. 
We first compared the objectives of the different 
initiatives. We then examined how each initiative 
identified and analysed aid in general and how each 
distinguished aid for RMNCH from other aid. As the 
Muskoka, IHME, and Countdown approaches have 
evolved over time, we focused on their latest methods at 
the time of our analysis.
To better understand how the differences in methods 
affected estimates of aid for RMNCH, we replicated the 
IHME and Muskoka methods for distinguishing aid for 
RMNCH from other types of aid in the Countdown 
Figure 1: Estimates of aid for RMNCH, 1990–2016
Different methods indicate different levels but similar trends in global aid. (A) Findings for all recipient countries. (B) Findings for the 75 priority countries as a group. RMNCH=reproductive, maternal, 
newborn, and child health. MNCH=maternal, newborn, and child health. IHME=Institute for Health Metrics and Evaluation. OECD=Organisation for Economic Co-operation and Development.
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Figure 2: Estimates of aid for 
RMNCH for 1990–2016 for 
each of the 24 bilateral 
donors
Different methods indicate 
different levels and trends in 
aid for RMNCH from individual 
donors. The 24 donors are 
longstanding members of the 
OECD Development Assistance 
Committee. EU=European 
Union. RMNCH=reproductive, 
maternal, newborn, and child 
health. MNCH=maternal, 
newborn, and child health. 
IHME=Institute for Health 
Metrics and Evaluation. 
OECD=Organisation for 
Economic Co-operation and 
Development.
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dataset,42 and restricted to the EU and 23 donor countries 
whose aid the IHME assessed in the Creditor Reporting 
System. We also compared the policy marker and the 
Muskoka methods in the June, 2017, Creditor Reporting 
System. We produced Sankey diagrams in SankeyMATIC 
(BETA) and line graphs in Microsoft Excel 2016 to 
illustrate how each method classified the same funding 
flows.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
All four approaches showed a large increase over time in 
aid for RMNCH, but their estimates of aid amounts 
differed by billions of dollars. Estimates for 2013 varied 
from $13·1 billion (Countdown RMNCH), $12·9 billion 
(Muskoka RMNCH), $10·8 billion (IHME MNCH), and 
$8·5 billion (Countdown MNCH), to just $2·0 billion 
(RMNCH policy marker; figure 1). RMNCH estimates 
from Muskoka and Countdown were highest and 
generally very similar. MNCH estimates from IHME 
were higher than those for Countdown in every year for 
which both produced estimates (2003–13) and were 
higher than both Muskoka and Countdown RMNCH 
estimates in 2002 and 2003. The OECD RMNCH policy 
marker generated the lowest estimates.
Estimates of aid for RMNCH for the 75 priority 
countries in 2013 varied from $12·2 billion (Countdown 
RMNCH) and $12·0 billion (Muskoka RMNCH), to 
$7·9 billion (Countdown MNCH), $5·5 billion (IHME 
MNCH), and $1·3 billion (RMNCH policy marker; 
figure 1). Unlike estimates for all recipients, the IHME 
MNCH estimates for the 75 priority countries were 
substantially lower than the Countdown MNCH 
estimates in all years for which both produced estimates 
(2003–13). For each year reported, Countdown indicated 
that the 75 priority countries received 88–93% of total 
aid for RMNCH and 88–92% of total aid for MNCH. 
Similarly, Muskoka indicated that the 75 priority 
countries received 87–94% of total aid for RMNCH. By 
contrast, the policy marker indicated that the 75 priority 
countries received 61–66% of all aid for RMNCH, and 
IHME indicated the 75 priority countries received just 
24–51% of all aid for MNCH (appendix).
Annual rates of change differed substantially between 
approaches in some years. For example, from 2007 to 
2008, Muskoka indicated a 16% increase in aid for 
RMNCH to all recipients, whereas the two Countdown 
estimates and IHME indicated 7–8% increases 
(appendix). For 2008–09, IHME indicated a 9% increase, 
compared with an increase of 25–31% with the other 
approaches. For 2013–14, the policy marker indicated a 
23% increase, compared with a 4% increase with 
Muskoka and an 8% increase with IHME (appendix).
Rankings, estimates, and trends for individual donors 
also differed substantially across approaches (figure 2; 
appendix). The USA was consistently the largest 
contributor of aid for RMNCH (appendix). However, 
estimates of US aid for RMNCH in 2013 varied from 
$5·4 billion (Muskoka RMNCH, including core 
multilateral contributions) and $4·5 billion (Muskoka 
RMNCH, excluding core contributions, and Countdown 
RMNCH), to $2·6 billion (IHME MNCH by source), 
$1·5 billion (Countdown MNCH), $0·7 billion (IHME 
MNCH by channel), and $0·6 billion (RMNCH policy 
marker). Only 12 of the 24 donors on which we focused 
applied the policy marker in all three agreed years 
(2013–15; Australia, Austria, Canada, Ireland, Italy, 
Japan, Korea, the Netherlands, Norway, Portugal, 
Sweden, and USA) and two did not apply it at all 
(Switzerland and UK).
For the 24 individual recipient countries on which 
we focused, the policy marker consistently resulted in 
the lowest aid estimates and IHME estimates tended to 
be the second lowest (figure 3). Muskoka and the 
two Countdown estimates were often similar, but the 
degree of similarity in aid levels and trends varied 
across recipients. For example, Muskoka and Countdown 
indicated substantial increases in funding over time 
for Angola, Chad, DR Congo, Lesotho, Somalia, and 
Swaziland, whereas IHME indicated consistently low 
funding for these countries (figure 3). We noted a similar 
positive relationship between RMNCH aid per child 
aged less than 5 years and child mortality for Muskoka 
and Countdown, but a much flatter relationship for 
IHME and the policy marker, involving extreme outliers 
(appendix).
To understand why the four approaches produced 
different estimates, we first examined their objectives. 
The Countdown, Muskoka, and policy marker approaches 
were developed to assess aid supporting RMNCH, 
whereas the IHME approach was developed to assess aid 
flows to the health sector and to characterise these flows 
by policy focus area (panel). This difference of objective 
affected how each approach distinguished aid for 
RMNCH from aid for other purposes, which in turn 
explained some of the differences observed in estimates 
and trends. However, there were also many further 
differences in methods—which we describe below—that 
were unrelated to this difference of objective and led to 
substantial differences in estimates.
All four approaches used the OECD Creditor Reporting 
System database as the main or only data source (table 1). 
Countdown supplemented the Creditor Reporting 
System with data obtained from Gavi, the vaccine 
alliance, on its disbursements in 2003–06. For estimates 
by donor, Muskoka used additional OECD data on 
donors’ core contributions to multilateral institutions. 
IHME made more substantial use of additional data 
For SankeyMATIC see 
http://sankeymatic.com/
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Figure 3: Estimates of aid for 
RMNCH for 1990–2015 for 
each of the 24 recipient 
countries
Different methods indicate 
different levels and trends in 
aid for RMNCH for individual 
recipient countries. No 
recipient-level data were 
available for 2016 from any of 
the four approaches at the 
time of our analyses. The 
24 recipient countries reflect 
the nine countries with the 
worst levels in 2013 in each of 
five indicators:45 maternal 
mortality ratio, number of 
maternal deaths, mortality 
rate in children younger than 
5 years, number of deaths in 
children younger than 5 years, 
and female life expectancy. 
RMNCH=reproductive, 
maternal, newborn, and child 
health. MNCH=maternal, 
newborn, and child health. 
IHME=Institute for Health 
Metrics and Evaluation. 
OECD=Organisation for 
Economic Co-operation and 
Development.
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Countdown Muskoka OECD RMNCH policy marker IHME
What time period do 
the estimates analysed 
in this Article cover?
2003–13 2002–15 (presented in this 
Article); 2006–14 (PMNCH 
reports)
2013–15 (donor reporting 
requested); 2010–15 (US reporting)
1990–2016 (global and donor-specific); 1990–2014 
(recipient-specific)
Which aid data 
sources are used?
OECD’s Creditor Reporting System 
database; missing data from Gavi, 
the vaccine alliance for 2003–06, 
replaced with data obtained 
directly from Gavi
OECD’s Creditor Reporting System 
database; for donor-specific 
estimates, Creditor Reporting 
System supplemented with 
additional OECD data tables on 
core contributions to multilaterals
OECD’s Creditor Reporting System 
database
For 23 donor countries and the EU, OECD Creditor 
Reporting System and Development Assistance 
Committee databases were combined; for other donors, 
institutions’ financial reports, audited financial 
statements, direct correspondence, and online databases; 
US tax filings; the Foundation Center’s grants database; 
and the annual report on charities registered with the US 
Agency for International Development were used46
Which flow types are 
included?
Official development assistance 
and private grants
Official development assistance Official development assistance 
(required to be coded) plus other 
official flows (optional to be coded)
Official development assistance, private grants, and 
donor administration costs
Which donors’ aid is 
included?
Data from all 84 donors reporting 
to Creditor Reporting System 
evaluated; 51 donors (31 countries 
and 19 multilateral institutions and 
the Bill & Melinda Gates 
Foundation) considered to have 
provided aid for RMNCH based on 
Countdown criteria
Data from all 84 donors reporting 
to Creditor Reporting System 
evaluated; 63 donors 
(38 countries and 25 multilateral 
institutions) considered to have 
provided aid for RMNCH based on 
Muskoka criteria
All 84 donors reporting to Creditor 
Reporting System asked to code 
data on their official development 
assistance (if any) and other official 
flows (if any) for 2013 onwards; 
33 donors (29 countries plus 
four multilateral institutions) coded 
any data with at least one non-zero 
value based on RMNCH policy 
marker criteria
Data from 36 of the 84 donors reporting to Creditor 
Reporting System evaluated using either Creditor 
Reporting System or other data sources; 34 of these 
84 donors (24 countries plus nine multilateral institutions 
and the Gates Foundation) considered to have provided 
aid for RMNCH based on IHME criteria; additionally, IHME 
evaluated data from Pan American Health Organisation, 
>1000 foundations, and >500 non-governmental 
organisations based in the USA, and from 
>100 international non-governmental organisations 
registered in the USA; numbers of these considered to have 
provided aid for RMNCH based on IHME criteria is unclear
How are RMNCH 
activities defined? (see 
appendix for details)
Broadly Broadly Broadly Narrowly
How is aid for 
RMNCH distinguished 
from other aid?
Analysts code each record 
individually according to one of 
27 codes in an activity-based 
RMNCH framework; depending on 
the code assigned, a combination 
of assumptions or year-specific and 
recipient country-specific financing, 
and health and demographic data 
define the proportion of the 
record’s value (0–100%) categorised 
as supporting RMNCH
Analysts categorise a proportion 
(0–100%) of the value of each 
record as supporting RMNCH 
based on the record’s Creditor 
Reporting System purpose code; 
the proportion associated with 
each purpose code reflects a 
combination of assumptions and 
data on financing, health, and 
demography in 2009 averaged 
across 49 low-income countries
Donors code each record to indicate 
whether approximately 0%, 25%, 
50%, 75%, or 100% of the funding 
supports RMNCH; analysts can use 
these codes to generate estimates
Analysts combine existing categories (eg, Creditor 
Reporting System purpose codes and multilateral 
institutions’ internal classification systems) with key term 
searches of descriptive text fields to classify funding as 
focused on either MNCH or other health focus areas (HIV, 
tuberculosis, malaria, other infectious diseases, health 
systems, non-communicable diseases, and other); where 
key terms indicate more than one health focus area for a 
record, its value is divided across focus areas in proportion 
to the number of key terms identified for each focus area
Are donor countries 
credited for their 
relevant contributions 
to multilateral 
institutions’ core 
budgets?
Some; donor countries credited for 
relevant contributions to 
multilaterals for which the recipient 
and purpose are specified, but not 
for core contributions to 
multilaterals’ general budgets
Mostly, donor countries credited 
for relevant earmarked 
contributions and for relevant core 
contributions to ten multilaterals; 
core contributions to the EU and 
other multilaterals not credited
As for Countdown Yes; all aid flows traced back to a government, 
corporate, or private source
How is aid to 
unspecified, global, 
and regional 
recipients treated?
Included in estimates for each 
recipient country and the 
75 priority countries
As for Countdown Excluded from estimates for each 
recipient country and the 75 priority 
countries
Regional funding included, and both unspecified and 
global funding excluded from estimates for each 
recipient country and the 75 priority countries
How are currency 
values adjusted for 
inflation and 
exchange rates?
Used OECD methods: first adjusted 
for inflation in each donor country, 
then converted to $US using 
average exchange rates in a single 
year (2015 for our analysis)
As for Countdown As for Countdown and Muskoka First converted each year’s aid to $US using average 
annual exchange rates, then applied US gross domestic 
product deflators, which account for inflation in the USA
How are estimates 
adjusted for under-
reporting and 
reporting lags?
Not adjusted Not adjusted; reporting lags 
addressed in text of PMNCH 
reports by providing indication of 
more recent trends in aid based 
on interviews with key donors
Not adjusted For earlier years, used commitments to estimate 
disbursements and inflated detailed Creditor Reporting 
System data to match aggregate Development Assistance 
Committee data; for the decade to 2014, minor 
adjustments to disbursements to match reported 
commitments; for the most recent 2 years, generated 
estimated disbursements using regression models
OECD=Organisation for Economic Co-operation and Development. RMNCH=reproductive, maternal, newborn, and child health. IHME=Institute for Health Metrics and Evaluation. PMNCH=Partnership for 
Maternal, Newborn & Child Health. MNCH=maternal, newborn, and child health. EU=European Union.
Table 1: Summary of key analytical choices
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sources. To estimate aid from donor countries and the 
EU, IHME combined the OECD Creditor Reporting 
System database with additional OECD data for 
1990–2014 and used donor budgets for 2015–16. For other 
donors, IHME used many other data sources (appendix).46
Official development assistance was the main or only 
aid flow tracked by each of the four approaches (table 1). 
The OECD defines official development assistance as 
funds that promote economic development and welfare 
in low-income and middle-income countries. Muskoka 
only tracked official development assistance. The policy 
marker also tracked other official flows, but these funds 
had a negligible effect on its RMNCH aid estimates. In 
addition to official development assistance, Countdown 
also tracked private grants (exclusively from the Gates 
Foundation), which comprised 5–6% of its RMNCH 
estimates for 2009–13, the years for which the Gates 
Foundation reported its grants to the Creditor Reporting 
System. IHME tracked official development assistance, 
private grants, and donor administration costs.39 Gates 
Foundation funding comprised 5% of IHME estimates 
and including donor administrative costs increased 
IHME aid estimates by 9% for 1990 and by 14% for 2015 
(IHME did not provide data tables on estimates of in-kind 
contributions, although this has been included in IHME’s 
latest report,36 so these proportions were estimated from a 
bar graph).
The four approaches assessed aid from different 
donors. Muskoka, Countdown, and the policy marker 
assessed aid from all 86 donors reporting to the Creditor 
Reporting System (table 1). IHME assessed funding from 
36 of these donors, and additional donors whose aid 
was not captured in the Creditor Reporting System. 
The 50 donors excluded from the IHME assessment 
accounted for only 1–2% of Muskoka and Countdown 
RMNCH estimates, and the additional donors assessed 
by IHME accounted for 7% of the IHME MNCH estimate 
in 2013.
Some initiatives excluded funding from large donors, 
which drove substantial differences in estimates. For 
example, the Muskoka method excluded private grants 
such as Bill & Melinda Gates Foundation funding; IHME 
excluded all disbursements from UNAIDS and the 
Global Fund from its MNCH estimates; and the OECD 
policy marker approach omitted major donors that did 
not use the policy marker, including the UK, which alone 
accounted for around 10% of Muskoka and Countdown 
RMNCH estimates in 2013.
To compare trends in the real value of money over 
time, the nominal values disbursed need to be adjusted 
to account for inflation (or deflation). Data must also be 
converted to a common currency. Countdown, Muskoka, 
and the policy marker converted disbursements using 
the OECD Development Assistance Committee deflators, 
a set of year-specific and donor-specific parameters that 
account for inflation in each donor’s economy and 
changes in exchange rates over time. IHME converted all 
currencies to $US for each year and then applied the 
USA gross domestic product deflator, which accounts for 
inflation in the US economy, to all funding. This process 
led to substantial differences in estimated aid levels and 
trends for all donors (except the USA). At the extremes, 
IHME estimates for Japan were up to 133% higher 
(in 1995) than they would have been had the Development 
Assistance Committee deflators been used, and estimates 
for Australia ranged from 38% lower (in 2001) to 
44% higher (in 2011; appendix).
Estimates of aid from individual donors (figure 2) were 
substantially affected by how each approach categorised 
the two types of funding that donor countries provide 
to multilateral institutions (eg, UN agencies, the World 
Bank, Gavi, and the EU; figure 4). Donor countries fund 
core budgets of multilaterals, which cover admini stration 
and activities directed by the multilateral, and provide 
earmarked funds, which allow the donor country to 
retain control over how funds are spent. IHME estimates 
of funding by source included both types of funding for 
multilaterals, whereas IHME estimates by channel 
included neither type of multilateral funding (including 
only direct bilateral expenditure). Countdown, Muskoka, 
and policy marker estimates by donor included 
earmarked but not core funding for multilaterals, 
meaning that they were not comparable with either of 
the IHME estimates. Muskoka’s additional estimates by 
Figure 4: Different categorisations of multilateral and bilateral funding
Funding flows from bilateral institutions and private and corporate institutions to recipient countries either 
directly or via multilateral institutions. The four approaches grouped and labelled these flows in different ways, 
which restricted the comparability of estimates of aid from individual countries or institutions across the different 
approaches. Adapted from the OECD47 and IHME.23 OECD=Organisation for Economic Co-operation and 
Development. IHME=Institute for Health Metrics and Evaluation.
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donor including core contributions to multilaterals31 
and IHME’s estimates by source both included the 
two types of support for multilateral institutions. The 
Muskoka approach indicated that core contributions 
to multilaterals constituted between 18% (USA) and 
71% (Finland) of aid for RMNCH from the 23 donor 
countries on which we focused (figure 2; appendix). 
IHME indicated that core and earmarked contributions 
together constituted between 50% (Germany) and 
94% (Finland) of aid for MNCH from the same countries 
over the same period (2002–15) (figure 2; appendix).
Estimates of the aid disbursed to individual recipient 
countries (figure 3) were substantially affected by 
how each approach treated aid disbursed to regions 
(eg, sub-Saharan Africa) and unspecified recipients. 
Countdown and Muskoka included a share of these 
regional and unspecified disbursements within estimates 
for individual recipient countries. Regional and un-
specified disbursements thus constituted more than 
20% of Countdown and Muskoka estimates for individual 
recipients and the 75 priority countries.
By contrast, IHME included regional disbursements 
but excluded disbursements to global and unspecified 
recipients from its estimates for individual recipient 
countries. The policy marker excluded disbursements to 
regional and unspecified recipients from their country-
specific estimates. These exclusions reduced policy 
marker country-specific estimates by around 30% and 
IHME estimates by around 55% on average (figure 1; 
appendix).
Muskoka, Countdown, and the policy marker reported 
estimates based on donors’ published disbursements, 
whereas IHME made substantial adjustments to account 
for donors’ under-reporting and reporting lags. These 
adjustments allowed IHME to report aid estimates over a 
much longer period. They also affected IHME estimates 
for the years when the other approaches also reported 
estimates, although adjustments for the decade through 
2014 were reported to be small. How IHME projections 
for 2015–16 compared with data reported subsequently is 
not clear.
The four approaches also differed in how they 
distinguished aid for RMNCH from aid for other 
purposes. We highlight differences in how each approach 
conceptualised aid for RMNCH and defined specific 
activities as relevant to RMNCH or not, and how this 
affected estimates.
Countdown, Muskoka, and the policy marker 
categorised aid as either supporting RMNCH or not. 
They defined RMNCH as a combination of demographic 
groups and health conditions and included activities not 
described as RMNCH, including investments in health 
conditions (such as HIV and other infectious diseases), 
health systems, and outside the health sector, if they were 
considered to support RMNCH directly. IHME divided 
the total value of aid for the health sector into mutually 
exclusive categories,48 and estimated the monetary value 
of health sector aid explicitly focused on MNCH, 
excluding aid targeting diseases, the health system, or 
other sectors, even if it directly benefited MNCH. For 
example, Muskoka, Countdown, and the policy marker 
would consider a project addressing malaria in pregnancy 
to support RMNCH, but IHME would require that the 
disbursement be assigned to maternal health or malaria 
or be divided between them; the full value could not be 
counted towards both maternal health and malaria 
estimates.
The policy marker had the broadest definition of 
RMNCH activities (appendix). Muskoka excluded 
research and the humanitarian sector, and Countdown 
excluded research and the water and sanitation sector. 
IHME had the narrowest definition, excluding HIV and 
other sexually transmitted infections, malaria, water and 
sanitation, funding from the USA’s National Institutes of 
Health, and humanitarian aid from its MNCH estimates. 
IHME included family planning in its MNCH definition, 
whereas Countdown classified family planning within 
RMNCH but not MNCH.
The differing treatment of HIV funding across 
approaches explained much of the difference in estimates 
and trends for several high-burden recipient countries 
(notably Lesotho and Swaziland) and for the USA, 
and thus some of the differences in overall estimates. 
IHME and Muskoka’s exclusion of humanitarian 
funding accounted for their consistently lower estimates 
for several conflict-affected countries (notably Central 
African Republic and Somalia) compared with Count-
down’s MNCH and RMNCH estimates (appendix).
Each approach used a different set of techniques to 
distinguish aid for RMNCH from aid for other purposes. 
As all approaches used the OECD Creditor Reporting 
System as their main or only data source, they all built on 
the structure of this system. Each Creditor Reporting 
System record reflects a disbursement for which a donor 
(including countries, multilateral institutions, and the 
Gates Foundation) has provided the value, recipient, year, 
and a text description of the funded activities, as well 
as other data. Donors must assign to each record a 
single Creditor Reporting System purpose code, which 
identifies the sector (eg, health or education) and the 
more specific development objective of the disbursement 
(figure 5).39
For the policy marker, donors were expected to provide 
additional data on every record they reported to the 
Creditor Reporting System for data from 2013 onwards. 
Donors needed to assign each record an integer score 
(0–4), indicating that approximately 0%, 25%, 50%, 75%, 
or 100% of the value of the record supported RMNCH.40
IHME classified health sector aid into ten health focus 
categories and 34 subcategories using several automated 
algorithms. Aid flowing through multilaterals was 
classified either within a single category (eg, UNICEF as 
newborn and child health) or by using the institution’s 
internal classification system or key term searches. Aid 
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provided directly from donor countries and the EU to 
recipient countries was classified using key term searches 
and Creditor Reporting System purpose codes. In cases 
where a record contained key terms for more than one of 
IHME’s categories, its value was divided across categories 
in proportion to the number of key terms for each 
category. A record described as prevention of vertical 
HIV transmission in the purpose code for sexually 
transmitted diseases including HIV/AIDS, for example, 
would be categorised in full to IHME’s HIV category and 
no portion of it would be counted towards IHME’s 
MNCH categories (figure 5).
Countdown analysts read the donor, purpose code, and 
descriptive text fields for each Creditor Reporting System 
record in all sectors and assigned one of 27 codes based 
on their relevance to RMNCH (figure 6). The proportion 
of the record’s value counted towards RMNCH estimates 
reflected assumptions and year-specific and country-
specific financing, health, and demographic data. For 
example, records coded as general funding for HIV were 
assumed to benefit child health in proportion to the 
share of children aged under 5 years in the population 
with HIV. The full value of projects to prevent malaria in 
pregnancy or vertical transmission of HIV were counted 
towards RMNCH (figures 5, 6).
The original Muskoka approach defined by the G8 
counted a proportion of funding as supporting RMNCH 
based on the existing Creditor Reporting System 
purpose code. For example, 88·5% of each disbursement 
with the malaria control purpose code was considered 
to support RMNCH. These purpose code-based 
percentages reflected assumptions and financing, 
health, and demo graphic data for 2009 averaged across 
49 low-income countries. Additionally, the Muskoka 
Figure 5: Creditor Reporting System purpose codes vs Muskoka and the OECD RMNCH policy marker to classify aid for RMNCH and other purposes, 2013–15
Sankey diagram showing how the same funding flows are categorised by the Creditor Reporting System sector and purpose codes, the Muskoka initiative, and the OECD RMNCH policy marker. Data in this 
diagram reflect all 2013–15 official development assistance flows from 24 bilateral donors (including the EU) in the June, 2017, version of the Creditor Reporting System database. OECD=Organisation for 
Economic Co-operation and Development. RMNCH=reproductive, maternal, newborn, and child health.
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method also counted a proportion of core contributions 
from donor countries to ten multilateral institutions 
towards RMNCH estimates. For example, 55% of each 
donor’s core contributions to UNICEF were counted 
toward estimates of its aid for RMNCH. These 
institution-based percentages reflected each multi-
lateral institution’s assessment of the proportion of 
its activities in 2009 that benefited RMNCH. Our 
donor-specific Muskoka estimates replicated this 
approach and extended it to the 24 donors on which we 
focused (figure 2). When the PMNCH generated 
Muskoka estimates of RMNCH disbursements for the 
75 priority recipients and the world’s 49 poorest 
countries, its analysts applied the purpose code-based 
fixed percentages to all donor disbursements in the 
Creditor Reporting System, which we replicated in 
generating global (figure 1) and recipient-specific 
estimates (figure 3).
When applying these procedures to identify aid for 
RMNCH within the same dataset, we found that the 
Muskoka approach classified 12% less overall funding 
as RMNCH than did Countdown (appendix). This 
proportion varied little over time (range 3–15), but 
varied across donors (–15 to 37) and the 24 recipient 
countries (–11 to 60; appendix). Countdown classified 
44% (39 to 48) less overall funding to MNCH than to 
RMNCH. IHME classified 37% less funding as MNCH 
than did Countdown (and 65% less funding than 
Countdown had classified as RMNCH); this proportion 
varied substantially over time (range 24 to 56), and 
across donors (19 to 87%) and recipients (–31 to 95%; 
appendix).
Figure 6: Creditor Reporting System purpose codes vs IHME and Countdown to classify aid for RMNCH and other purposes, 2003–13
Sankey diagram showing how the same funding flows are categorised by the Creditor Reporting System purpose and sector codes, the IHME, and the Countdown RMNCH aid tracking exercise. Data in 
this diagram reflect all 2003–13 official development assistance flows from 24 bilateral donors (including the EU) in the Countdown database. IHME procedures for allocating funding to different 
health sector categories were recreated based on their publications and personal communications. IHME=Institute for Health Metrics and Evaluation. RMNCH=reproductive, maternal, newborn, and 
child health. R*=family planning, sexual health, and sexually transmitted infections, including HIV.
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Discussion
The IHME, Muskoka, Countdown, and OECD policy 
marker approaches led to substantially different estimates 
of levels and trends in aid for RMNCH, especially for 
individual donors and recipient countries. These 
differences are large enough to lead to different 
conclusions about whether donors and recipient countries 
have fulfilled their obligations and com mitments and 
about the adequacy, targeting, and effectiveness of aid. As 
conclusions regarding past aid efforts can have important 
ramifications for future global health policies and 
funding, it is important that policy makers, advocates, 
and academics understand and recognise the limitations 
of the estimates they use so that they can draw appropriate 
conclusions (table 2).
We identified important differences and limitations in 
how the four initiatives identified and analysed aid in 
general, which are relevant for any aid tracking initiative. 
All four used the OECD Creditor Reporting System 
database and none included bilateral aid from China, 
Russia, India, or Brazil. None of the four initiatives have 
yet exploited the AidData database, which has recently 
added data from China and other non-Development 
Assistance Committee donors.49 Converting funding flows 
to $US before accounting for inflation (and therefore 
assuming US inflation reflected inflation rates of all 
countries) substantially altered IHME estimates and 
trends and reflected neither the opportunity cost to donors 
(except the USA) of giving nor to recipients of receiving 
the given nominal flows in one year rather than another. 
IHME’s complex methods of adjusting reported donor 
data for under-reporting and reporting lags allowed it to 
report estimates over a much longer period than the other 
approaches and might have improved the completeness 
of estimates, but the accuracy of these projections 
remains uncertain and such adjustments do not hold 
donors accountable for complete and accurate reporting. 
Estimates by recipient country were substantially affected 
by whether regional and unspecified allocations were 
included in estimates for individual countries. Estimates 
by donor were substantially affected by whether donor 
countries were credited for their support to multilateral 
institutions. Only Muskoka and IHME credited countries 
for their core funding to any multilateral institutions and 
only IHME credited European countries for aid provided 
through the EU; such crediting is important for ensuring 
that accountability mechanisms do not disincentivise 
support for multilateral cooperation and EU membership.
We also identified important differences and limitations 
in how each approach distinguished aid for RMNCH from 
aid for other purposes, which offer useful insights for 
tracking aid to any specific area. The four approaches had 
different objectives and so conceived of aid for RMNCH 
differently; Muskoka, Countdown, and the policy marker 
sought to estimate the monetary value of aid supporting 
RMNCH, whereas IHME sought to characterise the policy 
focus of aid to the health sector. As a result, IHME 
estimated the value of aid explicitly described as promoting 
RMNCH, excluding aid to diseases, the general health 
system, or non-health sectors, which substantially reduced 
its estimates relative to the other approaches. Donors often 
categorise health funding in emergency contexts as 
humanitarian rather than falling within the health sector, 
but IHME and Muskoka excluded humanitarian funding 
Countdown Muskoka OECD RMNCH policy marker IHME
Aim To estimate the monetary value of 
aid promoting RMNCH
As for Countdown As for Countdown and Muskoka To estimate the monetary value of 
development (not humanitarian) aid to the 
health sector and then to characterise the 
health focus areas of this aid
Appropriate uses 
of estimates of aid 
for (R)MNCH for 
each approach
Assess effectiveness of aid in 
improving coverage and health, 
assess adequacy of aid relative to cost 
estimates, granular donor-specific 
and recipient-specific analyses
Frequent global monitoring, more 
appropriate for global than donor-specific 
or recipient-specific analyses, assess 
adequacy of aid relative to cost estimates 
(especially at global level)
Limited to analyses of individual donors’ aid 
flows because few donors have provided 
complete data
Analyse donors’ priorities, eg, whether 
setting global goals led to changes in 
funding targeting RMNCH or specific 
diseases; granular donor-specific analyses of 
funding priorities
Advantages Exploits publicly available data, 
provides relatively precise estimates 
based on available data
Quick to implement, exploits publicly 
available data, fully transparent, agreed 
by donors and generates estimates they 
can predict, credits donor countries for 
their contributions to most major 
multilateral institutions (but not the EU), 
adaptable to new goals, replicable
Fully transparent, agreed by donors and 
generates estimates they can predict, 
quick for analysts to implement, replicable 
estimates (although donor coding is not 
replicable)
Longest time trends; estimates 
development aid for health sector as a 
whole; adaptable to new goals; fully credits 
donor countries for their contributions to 
multilateral institutions, including the EU; 
exploits some descriptive data on individual 
projects (using key terms)
Disadvantages Perceived subjectivity, complexity, 
labour-intensive to implement, 
open to human error in coding, not 
readily adaptable to new goals
Imprecise process for identifying aid; 
excludes humanitarian sector, so 
estimates of health aid biased against 
countries in crisis and donors focused on 
health in humanitarian contexts
Not readily adaptable to new goals; 
burdensome for donors; no robust trend 
analysis possible for global aid, recipients, 
or most donors, because of lack of data; 
relatively imprecise coding scheme; donors 
might code differently, making 
comparisons between donors problematic
Complexity; does not fully exploit publicly 
available data; excludes humanitarian 
sector, so estimates of health aid biased 
against countries in crisis and donors 
focused on humanitarian contexts
RMNCH=reproductive, maternal, newborn, and child health. OECD=Organisation for Economic Co-operation and Development. IHME=Institute for Health Metrics and Evaluation.
Table 2: Aims, appropriate uses, advantages, and disadvantages of the four approaches for estimating aid for RMNCH
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from their RMNCH estimates, which underestimated 
aid for RMNCH to crisis-affected countries. Despite 
increasing evidence of the effect on health investments 
in non-health sectors,50,51 only Muskoka included a 
portion of funding to the water and sanitation sector, and 
none of the approaches included activities in education, 
transport, or social protection.
To monitor funding supporting each SDG and the 
Global Strategy for Women’s, Children’s, and 
Adolescents’ Health, aid tracking methods should be 
built on a sound conceptual framework, which recognises 
that funding can simultaneously support multiple 
objectives.16 Consistent with the System of Health 
Accounts,52 such a framework must recognise that 
diseases and population groups necessarily overlap; 
funding oriented towards a category in one dimension 
(eg, health system functions) will also support categories 
in other dimensions (eg, diseases and population 
groups). For example, if a donor concentrated exclusively 
on addressing the crisis in human resources for health, 
its aid would simultaneously promote RMNCH and 
disease control efforts. This conceptualisation of aid 
supports adherence to aid effectiveness principles53 by 
decreasing pressure on donors to fund many separate 
projects, thereby reducing aid fragmentation and 
transaction costs, and increasing funding efficiency.54 
This approach also promotes a multi-sectoral approach 
and recognises the interdependent, rather than 
competing, nature of the SDGs. This conceptualisation 
is also consistent with the Global Financing Facility’s 
estimates of incremental financing needs for RMNCH 
and adolescent health (RMNCAH), which emphasise the 
role of malaria, HIV, and non-health sectors as key 
determinants of RMNCAH.55
Both IHME and Countdown used complex techniques 
to distinguish aid for RMNCH from other aid. Although 
their respective techniques were different (IHME’s were 
automated, whereas Countdown researchers manually 
coded records), these technical differences had far less 
effect on estimates than differences in whether the 
approaches included funding for diseases and other 
objectives in their RMNCH estimates. The policy marker 
coding framework appeared both simple and reasonably 
precise; however, because it relied on donors for coding 
and half of major health donors did not apply it 
consistently, its estimates were low and uninformative. 
The Muskoka method used high-level assumptions 
without project-level coding or review, which meant that 
its global estimates, which were similar to Countdown’s, 
were more reliable than its granular estimates 
(eg, by donor or recipient), which were more likely to be 
affected by misclassification. All four initiatives entailed 
many assumptions and none quantified the uncertainty 
in their estimates. To facilitate the classification of aid 
across multiple dimensions, some researchers have 
advocated for the OECD to adopt a matrix approach;56 
however, the Creditor Reporting System purpose code 
framework remains ill adapted to tracking aid for specific 
population groups or health conditions.
Our comparative analysis has several limitations. First, 
our role in producing the Countdown estimates might 
raise questions of bias in our comparisons. Our intimate 
knowledge of the Countdown methods gives us unique 
insight into both its strengths and weaknesses, which we 
have endeavoured to elucidate fairly, and we do not 
intend to produce further estimates using this approach. 
Second, we focused on comparing overall RMNCH 
estimates and have not compared subcategories therein, 
either because subcategories were not available (Muskoka 
and policy marker), or because of differences in sub-
category definitions (IHME and Countdown). Third, we 
sought to compare key methodological differences, but 
further analytical choices not explored here could also 
influence estimates.
We showed that tracking aid involves many analytical 
choices, which substantially affect estimates. Most of the 
choices made in the four approaches we compared were 
neither right nor wrong, but involved trade-offs between 
simplicity, timeliness, precision, accuracy, efficiency, 
flexibility, replicability, and the incentives created. We 
argue that the most appropriate methods depend on 
the objectives. The methods used for advocacy and 
accountability efforts should, we believe, prioritise timeli-
ness (so findings are up to date), simplicity (so findings 
are transparent for donors and advocates), replicability 
(so findings are verifiable and donors can predict them), 
efficiency (so findings are not overly expensive to 
produce), flexibility (so tracking methods can be adapted 
to shifting advocacy objectives), and creating positive 
incentives for donors. Of the four methods we compared, 
Muskoka best reflected these priorities. Building on our 
analysis, the PMNCH and Countdown to 2030 convened 
stakeholders in 2018 and are engaged in ongoing 
consultation and analysis regarding how best to improve 
the precision and accuracy of the Muskoka approach, 
while maintaining its speed, replicability, and positive 
incentives for donors. The methods used for tracking aid 
for research purposes should, we argue, prioritise the 
accuracy and precision of estimates, with due regard 
for efficiency. Such in-depth analyses could include 
assessments of the effect of aid on health outcomes, 
examination of levels and trends in aid for narrow areas 
and at a granular level, or development and validation of 
quick and simple methods for advocacy and accountability 
exercises. For such research, combining key term 
searches and Creditor Reporting System purpose codes 
with manual review of a restricted set of records might 
provide a suitable balance between rigour and efficiency. 
All future approaches should explore and communicate 
uncertainty in estimates.
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